TELA (STOCKS)
TELA Bio, Inc. Common Stock
$0.824000
-0.036000 (-4.19%)
Prev close: $0.860000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Antony Koblish
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $35.82M
- Employees
- 209
- P/E (TTM)
- -1.00
- P/B (TTM)
- -6.89
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
6
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.21 | $-0.19 | -0.0180 | -9.38% |
|
Dec 2025 (Q4)
|
$-0.17 | $-0.19 | +0.0163 | +8.75% |
|
Sep 2025 (Q3)
|
$-0.19 | $-0.20 | +0.0130 | +6.40% |
|
Jun 2025 (Q2)
|
$-0.22 | $-0.18 | -0.0397 | -22.02% |
Financial Statements
| Revenues | $80.81M |
| Benefits Costs and Expenses | $120.42M |
| Cost Of Revenue | $26.47M |
| Costs And Expenses | $120.42M |
| Gross Profit | $54.35M |
| Nonoperating Income/Loss | -$5.79M |
| Operating Expenses | $88.16M |
| Research and Development | $9.02M |
| Other Operating Expenses | $79.14M |
| Operating Income/Loss | -$33.81M |
| Income/Loss From Continuing Operations After Tax | -$39.84M |
| Income/Loss From Continuing Operations Before Tax | -$39.60M |
| Income Tax Expense/Benefit | $238.00K |
| Net Income/Loss | -$39.84M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$39.84M |
| Net Income/Loss Available To Common Stockholders, Basic | -$39.84M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.79 |
| Diluted Earnings Per Share | -$0.79 |
| Basic Average Shares | 149,639,623 |
| Diluted Average Shares | 149,639,623 |
| Assets | $69.89M |
| Current Assets | $64.30M |
| Accounts Receivable | $9.72M |
| Inventory | $12.21M |
| Other Current Assets | $42.37M |
| Noncurrent Assets | $5.59M |
| Fixed Assets | $2.16M |
| Intangible Assets | $1.26M |
| Other Non-current Assets | $2.17M |
| Liabilities | $75.09M |
| Current Liabilities | $17.83M |
| Accounts Payable | $3.89M |
| Wages | $5.76M |
| Other Current Liabilities | $8.18M |
| Noncurrent Liabilities | $57.26M |
| Equity | -$5.20M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$5.20M |
| Liabilities And Equity | $69.89M |
| Net Cash Flow From Operating Activities | -$29.66M |
| Net Cash Flow From Operating Activities, Continuing | -$29.66M |
| Net Cash Flow From Investing Activities | $898.00K |
| Net Cash Flow From Investing Activities, Continuing | $898.00K |
| Net Cash Flow From Financing Activities | $25.57M |
| Net Cash Flow From Financing Activities, Continuing | $25.57M |
| Net Cash Flow | -$3.20M |
| Net Cash Flow, Continuing | -$3.20M |
| Comprehensive Income/Loss | -$39.85M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$39.85M |
| Other Comprehensive Income/Loss | -$18.53M |